COVID-19: Vaccines and Therapeutics

The Food and Drug Administration granted full approval to the Moderna COVID-19 vaccine for individuals age 18 and older.
Eligibility for the COVID-19 vaccine has expanded to children, yet families continue to have questions about how to best keep their children safe and healthy. In this new podcast series, Joining Hands to Build Pediatric COVID-19 Vaccine Confidence, we are speaking with leaders from three national…
After being hospitalized for COVID-19, an Oregon man describes his yearlong journey recovering from long-haul COVID, encouraging others to stay healthy and get vaccinated.
Amid a resurgent COVID-19 and annual flu season, the AHA has released new resources that hospitals and health systems can use to encourage communities to stay healthy and protect themselves.
Based on recent data on omicron variant susceptibility to monoclonal antibodies, the Food and Drug Administration revised its emergency use authorizations for the combination therapies bamlanivimab and etesevimab and REGEN-COV (casirivimab and imdevimab) to exclude geographic regions where the…
Hospital leaders and clinicians will join experts from the Centers for Disease Control and Prevention, AHA and American College of Obstetricians and Gynecologists Jan. 26 to discuss how health care professionals can work with their patients and communities to build trust in the safety and efficacy…
The Food and Drug Administration expanded the approved uses for Vekury (remdesivir) to include non-hospitalized patients aged 12 and older who test positive for SARS-CoV-2, weigh at least 88 pounds and are at high risk of progressing to severe COVID-19.
According to data from 25 state and local health departments, adults who were unvaccinated against COVID-19 as the omicron variant emerged in December had nearly three times higher risk of infection than adults fully vaccinated against COVID-19 and five times higher risk than adults who had…